GLUT1 is thought to be the main glucose transporter in breast cancer (Adekola et al., 2012; Szablewski, 2013) and CAIX is a marker of hypoxia linked to carcinogenesis (van Brussel et al., 2013). This evidence concerns the gene SLC2A1 and breast cancer.